ConcertAI Appoints Michael Myshrall as Chief Financial Officer

ConcertAI, a pacesetter in oncology generative and agentic AI SaaS and multi-modal knowledge (MMD) options for healthcare and life sciences, at present introduced the appointment of Michael Myshrall as chief monetary officer (CFO). Myshrall brings over twenty years of monetary management expertise in SaaS, synthetic intelligence (AI) and expertise sectors, positioning him to assist speed up ConcertAI’s continued enlargement and innovation in AI-powered scientific analysis and care.

Myshrall joins ConcertAI following a distinguished profession main monetary operations for high-growth expertise corporations. Most lately, he served as CFO at Afiniti, a pacesetter in buyer expertise AI software program, the place he led a world finance group and helped navigate a fancy monetary recapitalization of the enterprise.

Beforehand, Myshrall served as CFO for NASDAQ-listed cybersecurity firm Cyren, the place he raised over $100 million in fairness and debt capital, together with a majority sale to non-public fairness agency Warburg Pincus. He was additionally CFO for PrimePay, a private-equity-backed human capital administration software program firm. His experience spans the complete spectrum of SaaS enterprise fashions, recurring income optimization and the monetary metrics important to scaling AI-driven healthcare applied sciences.

“Mike’s confirmed observe file of driving monetary excellence and operational scale makes him the perfect chief to information ConcertAI by means of our subsequent section of progress,” mentioned Eron Kelly, Chief Government Officer of ConcertAI. “His deep understanding of SaaS fashions, mixed along with his expertise in AI and expertise sectors, aligns completely with our mission to speed up breakthroughs in life sciences and healthcare by means of revolutionary AI options.”

Myshrall’s appointment comes as ConcertAI continues to increase its complete platform that unifies real-world knowledge, AI innovation, and scientific experience. The corporate’s built-in options span from drug discovery to scientific trials to affected person care supply, serving main pharmaceutical corporations and main healthcare establishments worldwide.

A Harvard Enterprise College Grasp of Enterprise Administration graduate and former administration marketing consultant, Myshrall has led mergers and acquisitions, capital elevating efforts and sophisticated monetary transactions all through his profession. His expertise contains profitable public choices, non-public fairness investments and the implementation of superior monetary planning and evaluation methods optimized for SaaS and AI enterprise fashions.

The publish ConcertAI Appoints Michael Myshrall as Chief Financial Officer first appeared on AI-Tech Park.